ConductScience.org, home

Paper3919944

Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.

Kessel D and 1 other. Cancer Res, 1985. Cited by 178 papers, by iCite.

Cite this record

ConductScience Library. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists. Papers, record 3919944. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3919944

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
PubMed
Journal
Cancer Res
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
178
iCite
Relative citation ratio, by iCite
6.73
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kessel DD
2Wilberding CC

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibiotics, AntineoplasticMajor topic
Calcium Channel BlockersMajor topic
Leukemia P388Major topic
Leukemia, ExperimentalMajor topic
Animals
Calcium
Cell Line
Daunorubicin
Drug Resistance
Egtazic Acid
Mice
Naphthacenes
RNA, Messenger

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA 31331NCI NIH HHSUnited StatesR01CA031331PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.

PMIDTitleJournalYearIn PapersSource
8807402Cellular drug efflux and reversal therapy of cancer.J Bioenerg Biomembr1996https://conductscience.org/library/papers/8807402PubMed
8100823Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/8100823PubMed
8004759Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8004759PubMed
7841045Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent.Br J Cancer1995https://conductscience.org/library/papers/7841045PubMed
7841041Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.Br J Cancer1995https://conductscience.org/library/papers/7841041PubMed
7765325Pharmacologic circumvention of multidrug resistance.Cytotechnology1993https://conductscience.org/library/papers/7765325PubMed
3947509Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.Br J Cancer1986https://conductscience.org/library/papers/3947509PubMed
3815723Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3815723PubMed
3741759Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.Br J Cancer1986https://conductscience.org/library/papers/3741759PubMed
3730255Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention.Br J Cancer1986https://conductscience.org/library/papers/3730255PubMed
3707847
Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells.
Br J Cancer1986https://conductscience.org/library/papers/3707847PubMed
3600053Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil.Med Oncol Tumor Pharmacother1987https://conductscience.org/library/papers/3600053PubMed
3457021Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.J Clin Invest1986https://conductscience.org/library/papers/3457021PubMed
3435701Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.Br J Cancer1987https://conductscience.org/library/papers/3435701PubMed
3284909Genetics of multidrug resistance.J Clin Invest1988https://conductscience.org/library/papers/3284909PubMed
3207599Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line.Br J Cancer1988https://conductscience.org/library/papers/3207599PubMed
3179186Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.Br J Cancer1988https://conductscience.org/library/papers/3179186PubMed
3165724Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3165724PubMed
3056253Endogenous active efflux of norfloxacin in susceptible Escherichia coli.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3056253PubMed
3028774A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain.EMBO J1986https://conductscience.org/library/papers/3028774PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3919944

GET https://conductscience.org/api/papers/v1/3919944/cited_by?page=2